In early September 2025, Veronika Skvortsova, head of Russia’s Federal Medical and Biological Agency (FMBA), announced a breakthrough. The Enteromix cancer vaccine had completed preclinical trials. The results showed strong safety and effectiveness. Authorities called the vaccine “ready for clinical use.” Enteromix is a personalized mRNA-based vaccine. It trains the immune system to recognize and […]